Cencora (COR) free cash flow

Free cash flow · fiscal 2025
$3.21B

Cencora (COR) generated free cash flow of $3.21B in fiscal 2025 (the year ended September 30, 2025). That is 7.0% higher than the $3.00B of fiscal 2024. Figures as of 18 Nov 2026, 11:49 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$3.21B
Change on fiscal 2024
+7.0%
Growth, 5 years
+11.8% a year
Growth, 10 years
−1.4% a year
Highest on record
$3.69Bfiscal 2015
Lowest on record
$585.68Mfiscal 2013
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Cencora free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow grew at a compound 11.8% a year; over ten years the rate was −1.4% a year. Across the 19 fiscal years on record (2007–2025), the highest was $3.69B in fiscal 2015 and the lowest $585.68M in fiscal 2013.

History · 19 fiscal years

Free cash flow by fiscal year

Cencora free cash flow, year by year

Cencora (COR) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$3.21B 7.0% up
2024$3.00B 13.2% down
2023$3.45B 56.5% up
2022$2.21B 1.0% down
2021$2.23B 21.3% up
2020$1.84B 9.7% down
2019$2.03B 89.2% up
2018$1.07B 3.6% up
2017$1.04B 61.8% down
2016$2.71B 26.5% down
2015$3.69B 207.5% up
2014$1.20B 104.9% up
2013$585.68M 50.0% down
2012$1.17B 15.8% up
2011$1.01B 8.5% up
2010$932.15M 46.1% up
2009$637.93M 6.4% up
2008$599.76M 45.3% down
2007$1.10B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Cencora and comparable companies
CompanyFree cash flowFiscal year
Takeda Pharmaceutical TAK¥626.77B2026
Cencora COR$3.21B2025
Boston Scientific BSX$3.40B2025
Cardinal Health CAH$4.53B2026
argenx ARGX$573.51M2025
Edwards Lifesciences EW$1.34B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on COR

Cencora, figure by figure

Cencora (COR) overview: price, valuation and scorecardAll health care companies by market value

Cencora free cash flow: questions and answers

What is Cencora's free cash flow?

Cencora (COR) generated free cash flow of $3.21B in fiscal 2025 (the year ended September 30, 2025). That is 7.0% higher than the $3.00B of fiscal 2024.

What is the growth rate of Cencora's free cash flow?

Over the five fiscal years to 2025 free cash flow grew at a compound 11.8% a year; over ten years the rate was −1.4% a year.

What are the highest and lowest free cash flow figures on record for Cencora?

Across the 19 fiscal years on record (2007–2025), the highest was $3.69B in fiscal 2015 and the lowest $585.68M in fiscal 2013.

How is Cencora's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Cencora it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Cencora (COR) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/COR/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.